PEDRO LUIS
SANCHEZ FERNANDEZ
Investigador en el periodo 2005-2006
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (32)
2023
-
Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care
Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269
2020
-
Machine Learning to Predict Stent Restenosis Based on Daily Demographic, Clinical, and Angiographic Characteristics
Canadian Journal of Cardiology, Vol. 36, Núm. 10, pp. 1624-1632
2016
-
Comparison of 1-Year Outcome in Patients with Severe Aorta Stenosis Treated Conservatively or by Aortic Valve Replacement or by Percutaneous Transcatheter Aortic Valve Implantation (Data from a Multicenter Spanish Registry)
American Journal of Cardiology, Vol. 118, Núm. 2, pp. 244-250
2015
-
Comparison of different bone marrow-derived stem cell approaches in reperfused STEMI: A multicenter, prospective, randomized, open-labeled TECAM trial
Journal of the American College of Cardiology, Vol. 65, Núm. 22, pp. 2372-2382
2012
-
Nanopartículas derivadas de válvula aórtica: sin evidencias de vida
Revista Espanola de Cardiologia, Vol. 65, Núm. 9, pp. 813-818
2011
-
Evolución a largo plazo de la función ventricular tras la terapia celular intracoronaria en el infarto agudo de miocardio
Revista Espanola de Cardiologia, Vol. 64, Núm. 4, pp. 334-337
2010
-
Absence of accelerated atherosclerotic disease progression after intracoronary infusion of bone marrow derived mononuclear cells in patients with acute myocardial infarction-Angiographic and intravascular ultrasound-Results from the TErapia Celular Aplicada al Miocardio Pilot study
American Heart Journal, Vol. 159, Núm. 6, pp. 1154.e1-1154.e8
-
Role of the paclitaxel-eluting stent and tirofiban in patients with st-elevation myocardial infarction undergoing postfibrinolysis angioplasty the GRACIA-3 randomized clinical trial
Circulation: Cardiovascular Interventions, Vol. 3, Núm. 4, pp. 297-307
2009
-
Análisis cuantitativo de la función ventricular izquierda como herramienta para la investigación clínica. Fundamentos y metodología
Revista Espanola de Cardiologia, Vol. 62, Núm. 5, pp. 535-551
-
Association of angiographic perfusion score following percutaneous coronary intervention for ST-elevation myocardial infarction with left ventricular remodeling at 6 weeks in GRACIA-2
Journal of Thrombosis and Thrombolysis, Vol. 27, Núm. 3, pp. 253-258
-
Comparison of Neointimal Hyperplasia With Drug-Eluting Stents Versus Bare Metal Stents in Patients Undergoing Intracoronary Bone-Marrow Mononuclear Cell Transplantation Following Acute Myocardial Infarction
American Journal of Cardiology, Vol. 103, Núm. 12, pp. 1651-1656
-
Dominant frequency differences in atrial fibrillation patients with and without left ventricular systolic dysfunction
Europace, Vol. 11, Núm. 4, pp. 450-457
-
Early translation of adipose-derived cell therapy for cardiovascular disease
Cell Transplantation, Vol. 18, Núm. 3, pp. 245-254
-
Mejora del pronóstico tras parada cardiorrespiratoria de causa cardiaca mediante el empleo de hipotermia moderada: comparación con un grupo control
Revista Espanola de Cardiologia, Vol. 62, Núm. 7, pp. 733-741
-
Panoramic view of the Fifth International Symposium on Stem Cell Therapy and Applied Cardiovascular Biotechnology, April 2008, Madrid (Spain)
Journal of Cardiovascular Translational Research
-
Prosthetic mitral thrombosis treated with two consecutive fibrinolytic administrations
Revista Espanola de Cardiologia
2008
-
Association between self-replicating calcifying nanoparticles and aortic stenosis: A possible link to valve calcification
European Heart Journal, Vol. 29, Núm. 3, pp. 371-376
-
Cooperative Cardiovascular Disease Research Network (RECAVA)
Revista Espanola de Cardiologia, Vol. 61, Núm. 1, pp. 58-65
-
European Heart Journal Supplements: Introduction
European Heart Journal, Supplement
-
Fibrinolytics and percutaneous coronary intervention
Clinical Guide to the Use of Antithrombotic Drugs in Coronary Artery Disease (CRC Press), pp. 177-186